QV Investors Inc. Trims Stock Holdings in Solventum Corporation $SOLV

QV Investors Inc. lowered its holdings in Solventum Corporation (NYSE:SOLV) by 2.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 218,692 shares of the company’s stock after selling 5,980 shares during the period. Solventum makes up about 1.3% of QV Investors Inc.’s holdings, making the stock its 28th biggest position. QV Investors Inc. owned about 0.13% of Solventum worth $16,872,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. CrossGen Wealth LLC bought a new position in Solventum in the 4th quarter worth approximately $25,000. Measured Wealth Private Client Group LLC bought a new stake in Solventum during the 3rd quarter valued at $25,000. Clearstead Trust LLC lifted its position in shares of Solventum by 61.0% during the first quarter. Clearstead Trust LLC now owns 396 shares of the company’s stock worth $26,000 after acquiring an additional 150 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new stake in shares of Solventum during the second quarter worth $28,000. Finally, Modus Advisors LLC bought a new position in shares of Solventum in the fourth quarter worth $30,000.

Analyst Ratings Changes

A number of research firms recently issued reports on SOLV. Weiss Ratings upgraded Solventum from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Tuesday, August 18th. Wall Street Zen downgraded Solventum from a “buy” rating to a “hold” rating in a research note on Saturday, August 22nd. Wells Fargo & Company reduced their target price on Solventum from $83.00 to $70.00 and set an “equal weight” rating for the company in a report on Wednesday, May 6th. UBS Group upped their price target on Solventum from $95.00 to $101.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Finally, BMO Capital Markets began coverage on shares of Solventum in a report on Wednesday, July 8th. They issued a “market perform” rating and a $81.00 price target on the stock. Eight research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Solventum has a consensus rating of “Moderate Buy” and an average price target of $91.64.

Solventum Stock Down 0.1%

SOLV opened at $91.02 on Monday. The company has a fifty day moving average price of $82.46 and a 200-day moving average price of $75.53. The firm has a market capitalization of $15.49 billion, a P/E ratio of 11.13, a price-to-earnings-growth ratio of 1.17 and a beta of 0.60. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.02 and a quick ratio of 0.74. Solventum Corporation has a one year low of $62.38 and a one year high of $92.71.

Solventum (NYSE:SOLV) last released its quarterly earnings results on Wednesday, August 5th. The company reported $2.55 earnings per share for the quarter, topping the consensus estimate of $1.91 by $0.64. The firm had revenue of $2.21 billion for the quarter, compared to analysts’ expectations of $2.15 billion. Solventum had a net margin of 17.26% and a return on equity of 25.09%. The business’s quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.69 earnings per share. Solventum has set its FY 2026 guidance at 7.100-7.200 EPS. Equities research analysts expect that Solventum Corporation will post 7.22 earnings per share for the current fiscal year.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.